Taking or not taking ADHD medication can have some important real-life consequences that extend into the realms of education, criminality, or substance abuse.
In a new research review, this common cholesterol-lowering medication does not cause the majority of side effects listed on ...
Only four of 66 undesirable outcomes attributed to statins were significant, according to a new study in the Lancet.
Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for patients taking blockbuster anti-obesity medications like Wegovy and Zepbound are ...
Kirstyn Hill has worked as a clinical pediatric and women’s health pharmacist since 2020. She was driven to work with a patient population that is not often able to easily speak up for themselves and ...
The popularity of GLP-1 weight-loss drugs has seen a seismic shift in just over a year. Not long ago, they were primarily used for diabetes. But now, that’s changing. In some markets, such as the US, ...
Oprah Winfrey says her use of GLP-1s has helped her lose more than weight – she's also lost her desire for alcohol. Winfrey tells People that her days of being able to "outdrink everyone at the table" ...
Tramadol, a popular opioid often seen as a “safer” painkiller, may not live up to its reputation. A large analysis of clinical trials found that while it does reduce chronic pain, the relief is modest ...
Last month, the Trump administration announced major plans to slash prices of GLP-1s, including Ozempic, Wegovy, Zepbound, and Mounjaro. The agreement will lower prices of these medications from ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. While extensive studies have found Covid-19 vaccines to be safe, effective, and to ...
As use of GLP-1 receptor agonists (RAs) continues to rise exponentially, awareness of its most common side effects, such as nausea and vomiting, is growing. But the drugs come with some lesser-known ...
Could 2026 be the year of the beautiful back end? We explore the range of options for server-side JavaScript development, from Express to Next and all the rest. A grumpy Scrooge of a developer might ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results